Experience
Roivant Scientists
Drafted and negotiated a complex strategic development agreement for Roivant Sciences relating to a small molecule product with potential payments of up to $600 million.
BioDelivery Sciences International, Inc. et al. v. Alvogen PB Research & Development LLC et al.
BioDelivery Sciences International, Inc. et al.
Chiron Corp. v. Eli Lilly and Vertex Pharmaceutical
Eli Lilly and Vertex Pharmaceuticals
BCL-2 inhibitors licensing agreement for Fochon Pharmaceuticals, Ltd.
Fochon Pharmaceuticals, Ltd.
Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement
Eisai Co., Ltd.
L'Oreal
Prosecuting patents for startup Hutchison Medipharma
Hutchison Medipharma
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.